-
Mashup Score: 3RAS(ON) Inhibitor Zoldonrasib Is Safe, Shows Early Activity Signals in KRAS G12D–Mutated PDAC - 2 day(s) ago
Zoldonrasib was well tolerated and associated with manageable AEs and preliminary antitumor activity in patients with KRAS G12D–mutated PDAC.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3RAS(ON) Inhibitor Zoldonrasib Is Safe, Shows Early Activity Signals in KRAS G12D–Mutated PDAC - 2 day(s) ago
Zoldonrasib was well tolerated and associated with manageable AEs and preliminary antitumor activity in patients with KRAS G12D–mutated PDAC.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
RAS(ON) Inhibitor Zoldonrasib Is Safe, Shows Early Activity Signals in KRAS G12D–Mutated PDAC @AlexSpiraMDPhD @ASCO #GI25 #pansm #oncology https://t.co/KgbZch9Kz7
-
RAS(ON) Inhibitor Zoldonrasib Is Safe, Shows Early Activity Signals in KRAS G12D–Mutated PDAC @AlexSpiraMDPhD @ASCO #GI25 #pansm #oncology https://t.co/KgbZch9Kz7